Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02875353 · ClinicalTrials.gov registry record · NA
Blood Flow Monitoring to Prevent Post-Polypectomy Induced Ulcer Bleeding
A NA study of Delayed Post-Polypectomy Induced Ulcer Hemorrhage, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 3
- Study locations
NCT02875353: Active NA study of Delayed Post-Polypectomy Induced Ulcer Hemorrhage, sponsored by VA Office of Research and Development.
NCT02875353 is a NA study of Delayed Post-Polypectomy Induced Ulcer Hemorrhage that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 180 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02875353, a NA study of Delayed Post-Polypectomy Induced Ulcer Hemorrhage, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 3
- Study locations
Study Summary
The primary specific aim is to perform a randomized controlled trial (RCT) to compare rates of delayed hemorrhage after DEP detection of arterial blood flow and focal treatment in PPIU's (treatment arm) with standard treatment using medical guidelines alone (controls) for prevention of delayed bleeding in high risk patients (on anti-coagulants or anti-platelet drugs or with large ulcers) after snare resection of benign colon polyps.
Primary Outcome
We will compare the proportion of participants with PPIU bleeding by 30 days follow up in Doppler endoscopic probe (DEP) versus standard treatment. The p value for testing this hypothesis will be computed using Fisher's exact test. The corresponding 95% confidence bounds for the true difference will also be reported.
Conditions Studied
Interventions
- DEVICE Doppler Endoscopic Probe
Study Locations (3)
California
- Kaiser Permanente-Downey Medical Center - Downey
- University of California, Los Angeles, Ronald Reagan Medical Center - Los Angeles
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA - West Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2026-05-29 |
| Phase | NA |
What the registry record for NCT02875353 still lists
NCT02875353 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Delayed Post-Polypectomy Induced Ulcer Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which Doppler Endoscopic Probe is the first listed.
NCT02875353 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02875353 about?
NCT02875353 is a clinical study titled "Blood Flow Monitoring to Prevent Post-Polypectomy Induced Ulcer Bleeding". The primary specific aim is to perform a randomized controlled trial (RCT) to compare rates of delayed hemorrhage after DEP detection of arterial blood flow and focal treatment in PPIU's (treatment arm) with standard treatment using medical guidelines alone (controls) for prevention of delayed bleed...
What is the current status of trial NCT02875353?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2017-02-15. Estimated completion is 2026-05-29.
What conditions does trial NCT02875353 study?
This clinical trial studies the following conditions: Delayed Post-Polypectomy Induced Ulcer Hemorrhage.
What interventions are being tested in trial NCT02875353?
The interventions under investigation include: Doppler Endoscopic Probe (DEVICE).
Who is sponsoring clinical trial NCT02875353?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02875353 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02875353's enrollment target sits among peer trials
180 586th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI